InterVene’s BlueLeaf Endovenous Valve Formation System granted breakthrough device designation by the FDA

13 December 2021 - InterVene announced today that it has received breakthrough device designation by the FDA for the company’s BlueLeaf ...

Read more →

Cytokinetics announces receipt of breakthrough therapy designation from FDA for aficamten

9 December 2021 - FDA granted designation for the treatment of symptomatic obstructive hypertrophic cardiomyopathy Based on results of REDWOOD-HCM. ...

Read more →

Linus Biotechnology receives FDA breakthrough device designation for StrandDx-ASD exposome sequencing diagnostic

7 December 2021 - Linus Biotechnology  today announced that the U.S. Food and Drug Administration Center for Devices and Radiological Health ...

Read more →

RefleXion receives breakthrough device designation for lung cancer treatment

1 December 2021 - RefleXion Medical today announced that the U.S. FDA has granted the company breakthrough device designation for ...

Read more →

ZetaMet receives breakthrough device designation from U.S. FDA for treatment of metastatic bone cancers

1 December 2021 - The technology is a first of its kind molecular pathway designed to suspend cancer, inhibit pain, and ...

Read more →

Silverlon receives FDA breakthrough device designation for radiation dermatitis and cutaneous radiation injury

30 November 2021 - Innovative Silverlon silver plated nylon dressing contains more metallic silver than any other dressing; anti-microbial properties of ...

Read more →

AMF Medical receives FDA breakthrough device designation for its Sigi insulin management system

30 November 2021 - Sigi is the only insulin patch pump for closed loop integration designed for use with standard, pre-filled ...

Read more →

Blackrock Neurotech's MoveAgain brain computer interface system receives breakthrough device designation from the FDA

16 November 2021 - Blackrock Neurotech today announces that the U.S. FDA has granted breakthrough device designation for its groundbreaking ...

Read more →

HAGAR GWave awarded FDA breakthrough device designation

23 November 2021 - Expediting development of GWave technology that may potentially improve the health and quality of life for millions ...

Read more →

Pear Therapeutics receives FDA breakthrough device designation for prescription digital therapeutic candidate to treat alcohol use disorder

22 November 2021 – Pear Therapeutics today announced that it has received breakthrough device designation from the U.S. FDA for ...

Read more →

FDA grants breakthrough designation for early stage breast cancer detection blood test developed by Datar Cancer Genetics

19 November 2021 - TriNetra is a circulating tumour cell detection blood test which is able to identify early stage ...

Read more →

FDA grants Theradaptive breakthrough medical device designation

19 November 2021 - Theradaptive announced that the U.S. FDA has granted breakthrough medical device designation to its Osteo-Adapt SP Spinal ...

Read more →

CMS repeals MCIT/R&N rule; will consider other coverage pathways to enhance access to innovative medical devices

12 November 2021 - Today, CMS is rescinding the Medicare Coverage of Innovative Technology and Definition of “Reasonable and Necessary” (MCIT/R&N) ...

Read more →

Man & Science announces U.S. FDA breakthrough device designation granted for the treatment of chronic cluster headache

8 November 2021 - Man & Science announced today that it has been granted a breakthrough device designation by the Center ...

Read more →

FDA awards breakthrough device designation to the ReWalk ReBoot Soft Exo-Suit

4 November 2021 - Soft exoskeleton device for stroke survivors will be for use at home and in the community ...

Read more →